Stock Events

Stock Events

BioHarvest Sciences 

$6.09
15
+$0+0% Monday 20:00

Statistics

Day High
6.33
Day Low
6.1
52W High
7.38
52W Low
0
Volume
1,034
Avg. Volume
10,676
Mkt Cap
119.46M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26FebExpected
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-0.48
-0.33
-0.19
-0.04
Expected EPS
-0.1223281113
Actual EPS
N/A

Financials

-51.27%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
50.38MRevenue
-25.83MNet Income

Analyst Ratings

10Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CNVCD. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1.02B
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, competing in the cannabis market space with BioHarvest Sciences.
Canopy Growth
CGC
Mkt Cap467.04M
Canopy Growth Corporation is a cannabis company with a wide range of cannabis and hemp products, competing directly with BioHarvest Sciences in the cannabis product market.
Tilray Brands
TLRY
Mkt Cap632.71M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, making it a direct competitor to BioHarvest Sciences in the cannabis industry.
Aurora Cannabis
ACB
Mkt Cap204.58M
Aurora Cannabis is engaged in the production and distribution of medical cannabis, competing with BioHarvest Sciences in the medical cannabis sector.
Organigram Global
OGI
Mkt Cap157.67M
OrganiGram Holdings is a producer and seller of medical and recreational cannabis, directly competing with BioHarvest Sciences in the cannabis market.

About

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.
Show more...
CEO
Dr. Zaki Rakib Ph.D.
Country
Canada
ISIN
CA09076J2074

Listings

XNAS
US
BHST
F
DE
8MV0.F
MU
DE
8MV0.MU
OTCM
US
CNVCD

0 Comments

Share your thoughts

FAQ

What is BioHarvest Sciences stock price today?▼
The current price of CNVCD is $6.09 USD — it has increased by +0% in the past 24 hours. Watch BioHarvest Sciences stock price performance more closely on the chart.
What is BioHarvest Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioHarvest Sciences stocks are traded under the ticker CNVCD.
What is BioHarvest Sciences market cap?▼
Today BioHarvest Sciences has the market capitalization of 119.46M
What is BioHarvest Sciences revenue for the last year?▼
BioHarvest Sciences revenue for the last year amounts to 50.38M USD.
What is BioHarvest Sciences net income for the last year?▼
CNVCD net income for the last year is -25.83M USD.
In which sector is BioHarvest Sciences located?▼
BioHarvest Sciences operates in the Other sector.
When did BioHarvest Sciences complete a stock split?▼
The last stock split for BioHarvest Sciences was on June 03, 2024 with a ratio of 1:35.
Where is BioHarvest Sciences headquartered?▼
BioHarvest Sciences is headquartered in Vancouver, Canada.